J. Attanucci

发表

Bone marrow‐derived dendritic cells pulsed with a tumor‐specific peptide elicit effective anti‐tumor immunity against intracranial neoplasms

M. Lotze, W. Chambers, H. Okada, 1998, International journal of cancer.

Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.

M. Lotze, A. Gambotto, W. Chambers, 2001, Cancer research.

Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.

Simon C Watkins, D. Kondziolka, T. Witham, 2002, Cancer research.

Combination of stereotactic radiosurgery and cytokine gene-transduced tumor cell vaccination: a new strategy against metastatic brain tumors.

D. Kondziolka, T. Witham, A. Niranjan, 2001, Journal of neurosurgery.

Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

M. Lotze, W. Chambers, H. Okada, 1999, Gene Therapy.

Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy

I. Pollack, M. Lotze, W. Chambers, 2000, Cancer Gene Therapy.

Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.

I. Pollack, M. Lotze, W. Chambers, 2000, Cancer research.

Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells

H. Okada, M. Lotze, I. Pollack, 2001, Gene Therapy.

Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.

D. Kondziolka, L. Lunsford, F. Lieberman, 2001, Human gene therapy.

Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.

D. Kondziolka, L. Lunsford, F. Lieberman, 2000 .

Essential for Protective Immunity T Cells by Interleukin-4-transfected 9 L Gliosarcoma Is + Cytokine Gene Therapy of Gliomas : Induction of Reactive CD 4 Updated Version

I. Pollack, M. Lotze, W. Chambers, 2000 .

Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.

D. Kondziolka, L. Lunsford, H. Edington, 2000 .